When used with HER2/neu DNA vaccine, the molecular adjuvant encoding mouse CCl4 can increase the proliferation of T lymphocytes and the production of specific antibody reaction, and inhibit the growth of tumor [20]. This evidence concerns the gene ERBB2 and neoplasm.